TL;DR: Asher Bio is a Y Combinator Summer 2019 startup We build better immunotherapies, currently active with a team of 3.
We build better immunotherapies
Last verified:
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
Built by LemStudio
Yes. Asher Bio was funded by Y Combinator in the Summer 2019 batch. We build better immunotherapies
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. O…
Asher Bio was part of Y Combinator's Summer 2019 batch.
Asher Bio has a team of 3 people according to Y Combinator's directory.
Asher Bio is currently listed as Active with a team of 3 in Y Combinator's directory.
Loading interactive view…